3D Printed Personalized Colon-targeted Tablets: A Novel Approach in Ulcerative Colitis Management

Curr Drug Deliv. 2023 Sep 15. doi: 10.2174/1567201821666230915150544. Online ahead of print.ABSTRACTUlcerative colitis (UC) and Crohn's disease (CD) are two types of idiopathic inflammatory bowel disease (IBD) that are increasing in frequency and incidence worldwide, particularly in highly industrialized countries. Conventional tablets struggle to effectively deliver anti-inflammatory drugs since the inflammation is localized in different areas of the colon in each patient. The goal of 3D printing technology in pharmaceutics is to create personalized drug delivery systems (DDS) that are tailored to each individual's specific needs. This review provides an overview of existing 3D printing processes, with a focus on extrusion-based technologies, which have received the most attention. Personalized pharmaceutical products offer numerous benefits to patients worldwide, and 3D printing technology is becoming more affordable every day. Custom manufacturing of 3D printed tablets provides innovative ideas for developing a tailored colon DDS. In the future, 3D printing could be used to manufacture personalized tablets for UC patients based on the location of inflammation in the colon, resulting in improved therapeutic outcomes and a better quality of life.PMID:37718525 | DOI:10.2174/1567201821666230915150544
Source: Current Drug Delivery - Category: Drugs & Pharmacology Authors: Source Type: research